Short in Medical Technology

NPS Reports Successful GATTEX(TM) Extension Study

... 3-extension study of GATTEX(TM) (teduglutide) for short bowel syndrome (SBS) patients who are ... Phase 3 study of GATTEX in which 83 patients with short bowel syndrome (SBS) received either a low dose ... the regulatory pathway for GATTEX. About short Bowel Syndrome (SBS) SBS is a highly disabling ...

Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)

... on the seven derived MOS-sleep scales: awakened short of breath or with headache, snoring, ... 0.0001). MOS-sleep scales measuring awakened short of breath or with headache and snoring were not ... 0.0173). MOS-sleep scales measuring awakened short of breath or with headache, snoring, adequacy ...

Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study

... recombinant GLP-2) in which 83 patients with short bowel syndrome (SBS) received either a low dose ... the greatest potential for effectively treating short bowel syndrome by improving nutrient absorption, ... patients with parenteral nutrition (PN)-dependent short bowel syndrome. Eighty three (83) patients who ...

Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome

... (FDA) for the treatment of children with short stature associated with Turner syndrome. ... many as 10 percent of all miscarriages worldwide. short stature is the most common feature associated ... on the chromosomal abnormalities). "Treatment of short stature in girls with Turner syndrome is the ...

Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome

... (FDA) for the treatment of children with short stature associated with Turner syndrome. ... many as 10 percent of all miscarriages worldwide. short stature is the most common feature associated ... on the chromosomal abnormalities). "Treatment of short stature in girls with Turner syndrome is the ...

Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference

... proprietary RECALL-VAX(TM) technology combines a short fragment of beta-amyloid with part of the tetanus ... harmful human beta-amyloid T-cell epitopes. The short fragments of beta-amyloid used in RECALL-VAX(TM) ... targeted by the antibodies, and because of their short length, the fragments are incapable of provoking ...

Video: New Research Discovers Independent Brain Networks Control Human Walking

... adaptations studied here represent a form of short term learning from practicing on this unusual ... the phenomenon of brain plasticity can occur in short intervals. When subjects returned to normal ... damage can store a new walking pattern in the short term. Based on these findings, Bastian's goal is ...

Is Your Hair Taking a Break?

... many women, their hair is one of their most defining characteristics. From short and sassy bobs to long, cascading curls, the right hairstyle can make any ... hair loss, the hair stays on the head for a shorter time due to a short growth phase, resulting in baby fine hairs that do not reach their full ...

University of Redlands Student Cody Unser Documentary Run to Start Today in L.A.

... Al Unser Jr., will graduate from the University of Redlands in a few short weeks after crafting a degree in biopolitics through the school's ... to design their own degrees. When Cody was 12, her breath went short and her legs numb during a school basketball game. It hit fast, and left ...

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring

... with no effect on adaptive pain or position sense. Adlea generally has a short half-life of 1 to 2 hours. It is undetectable in blood sample analyses after 24 hours. Adlea's short duration of systemic exposure (hours) relative to the long duration of ...

FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes

... to children 4 years and older." Apidra(R) has a rapid onset and short duration of action and should normally be used in combination with a ... 15 minutes before or within 20 minutes after starting a meal. Due to the short duration of action of Apidra(R), patients also require a longer-acting ...

Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery

... and localized desensitization of the pain fibers. The drug generally has a short half-life of 1 to 2 hours, and is undetectable in the blood after 24 hours. Adlea's short duration of systemic exposure relative to the longer duration of analgesia ...

Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times

... success in isolating 98 percent of pulmonary veins with a remarkably short average ablation time of 84 +/- 9 minutes. The total time of ... or robotic steering, could be performed safely and effectively with short procedure times," stated Dr. Weber. "Thus, this system may be of high ...

Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications

... patient to breathe. The surgery is done on an outpatient basis, with a short rehabilitation period. The patient then has the NeuRx DPS(TM) programmed ... weak and at first the patient can use the NeuRx DPS(TM) to breathe for a short period of time. The patient must condition and strengthen the diaphragm to ...

A Drug With Efficacy Superior to That of Xenical at Inducing Weight Loss Would Earn a 40 Percent Patient Share in the Obesity Drug Market

... to get approval. The new report entitled Obesity: Current Pipeline Falls short of Physicians' Expectations for Efficacy and Safety finds that Vivus's ... treatment." About the Report Obesity: Current Pipeline Falls short of Physicians' Expectations for Efficacy and Safety is a DecisionBase 2008 ...

Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement

... and localized desensitization of the pain fibers. The drug generally has a short half-life of 1 to 2 hours, and is undetectable in the blood after 24 hours. Adlea's short duration of systemic exposure relative to the longer duration of analgesia ...

Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy

... and localized desensitization of the pain fibers. The drug generally has a short half-life of 1 to 2 hours. It is undetectable in blood sample analyses after 24 hours. Adlea's short duration of systemic exposure (hours) relative to the long duration of ...

Novavax Reports Fourth Quarter and 2007 Year-End Financial Results

... 2007 versus the prior year, was principally due to lower average cash and short term investment balances in 2007. The relatively small change for the full ... expense, partially offset by lower interest income due to lower cash and short term investment balances in 2007 as compared to 2006. Accordingly, the ...

Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children

... injection site. Reactions were reported for the most part as mild and of short duration. Solicited systemic reactions were similar among the study groups and were described for the most part as mild, reversible and of short duration. The most common solicited complaints among children 2 years ...

Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia

... profound block trial, 110 patients undergoing elective surgery requiring short duration of neuromuscular relaxation were randomized to receive either an ... start of rocuronium administration or received an intubating dose of the short acting muscle relaxant succinylcholine of 1.0 mg/kg to be followed by ...

Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases

... (weeks to months). Currently drops, periocular injections and intraocular injections are used to deliver medications to the eye but generally for short periods of time. Dr. Murphree, who is a recipient of a National Institutes of Health RAID grant which provides funding for the development of ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... development. Our partnership strategy not only allows our drugs to move forward effectively toward the market but also provides us with significant short and intermediate term financial benefits that enable us to continue to advance the technology and fill the pipeline with more exciting new drugs," ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

... that it will become permanent is thought to increase with the length of therapy and the total dose received. This condition can also develop after a short period of treatment at low doses but this is less common. There is no known treatment for TD but it may go away partially or completely if the ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... and 2007. Study subjects (the test group) were asked to complete the widely-used and validated Italian version of the "Medical Outcome Study 36-Item short Form Questionnaire (SF-36)" that is utilized by psychologists to assess the quality of life of patients. The test allows for detailed analysis of ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... alopecia: Due to the influence of male hormones during and after puberty, thick and long hair does not regenerate but is replaced with thin and short soft hair, and consequently the hair follicles become atrophied, reducing the quantity of hair, localized from the parietal to the frontal region. ...

New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation

... The new comparative effectiveness report found that the procedure has been shown to provide benefits in maintaining normal heart rhythm over short periods of time (up to 1 year) but found little evidence indicating whether the procedure reduces the chance that patients will experience atrial ...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

... intravenous and epidural administration. Although the analgesic efficacy of sufentanil has been well established, its use has been limited due to its short IV plasma half-time. In the NanoTab oral transmucosal dosage form, sufentanil demonstrates a therapeutically appropriate pharmacokinetic profile for ...

Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications

... a year from incorporation in Hong Kong, Pangu BioPharma has demonstrated how well the government, university and industry partnership works. In that short time, with the support of HKUST and funding from the ITC, we have attracted a highly skilled group of scientists, established a well quipped lab at ...

Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis

... by the Bath Ankylosing Spondylitis Metrology Index (BASMI). Improvements in Mental Component Summary (MCS) and Physical Component Summary (PCS) short Form (SF)-36 questionnaire scores were also maintained through two years. "The sustained symptom relief demonstrated in these Phase 3 studies ...

New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform

... after they become sick." "We know that strategic investments in disease prevention programs in communities can result in a big payoff in a short time -- reducing health care costs, increasing the productivity of the nation's workforce, and helping people lead healthier lives," said Risa ...

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight

... rise during a meal to help the body utilise and control the elevation in blood sugar levels. However, GLP-1 is rapidly degraded, resulting in its short duration of action. In people with type 2 diabetes, GLP-1 secretion in response to a meal is reduced. Albiglutide is the only medication which fuses ...

Celladon Provides MYDICAR(R) Program Update of First-In-Human Trial for Advanced Heart Failure at American Society of Gene Therapy Annual Meeting

... (rAAV) vector that transfers the SERCA2a gene into heart muscle cells. MYDICAR is delivered in a single dose directly to the heart muscle during a short outpatient procedure, performed in a standard cardiac catheterization laboratory via a small incision in the upper leg. Of the twelve patients ...

Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial

... all," said Dr. Molyneux. "The positive trial results should reassure patients and physicians that treatment with endovascular coiling is safe in the short term while also providing a long-term benefit of lower death risk compared to surgical intervention. The latest data continue to support the general ...

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials

... solanezumab appeared to have dose-dependent effects on amyloid beta in blood and cerebrospinal fluid. The clinical studies to date have been too short to evaluate any potential delay in the progress of Alzheimer's disease. To date, the only side effect experienced in clinical studies that appeared ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... is a tropical tree that is one of the highest yielding oilseed plants in the world; it can be grown on marginal, non-food producing lands; has a very short generation time; can be productive for 30 to 40 years; and its seed oil and biomass are ideal for biofuel production. Jatropha is a non-domesticated ...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

... point along the road to bringing this important, next-generation technology to the global market, and the implanting of three devices in such a short period gives testimony to its benefit and the commitment and belief of cardiothoracic surgeons in Europe and the U.S. in its potential. We continue ...

Pivotal Data Show Bronchial Thermoplasty Can Improve Quality of Life and Reduce Asthma Attacks and Emergency Room Visits for Adults with Severe Asthma

... effectiveness endpoint was the change from baseline in Asthma Quality of Life Questionnaire (AQLQ) score. Safety was assessed by comparing the short and long-term safety profiles for both the treatment and sham control groups. Key statistically significant clinical findings of the AIR2 Trial ...

DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms

... By dramatically increasing the cell density of a culture, the XD(R) Technology offers the opportunity to substantially increase titers in a very short time without changing the cell line or process media. This can economically save a project already advanced in clinical development and prevent loss ...

Bionovo Announces First Quarter 2009 Highlights and Financial Results

... of $3.9 million, or $0.05 per share, for the same period in 2008. The Company ended the quarter with $9.1 million in cash, cash equivalents and short term investments, and began the quarter with $13.6 million, a difference of $4.5 million. The cash balance at the end of the quarter reflects the ...

HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials

... as extremely high levels of these infectious agents. Real-time PCR enables the production of large quantities of DNA from very small samples in a short period of time, making it possible to detect extremely low levels of a virus's genetic material. The Abbott m 2000 system automates the important ...